维普中文期刊产品整合服务
453篇 您的检索式:作者名="SIDDIQUI J"
    题名 作者 年代 出处 被引量
1Defining response to radiotherapy in rectal cancer using magnetic resonance imaging and histopathological scales显示文摘AIM To define good and poor regression using pathology and magnetic resonance imaging(MRI) regression scales after neo-adjuvant chemotherapy for rectal cancer.METHODS A systematic review was performed on all studies up to December 2015, without language restriction, t h a t w e r e i d e n t i f i e d f r o m M E D L I N E, C o c h r a n e Controlled Trials Register(1960-2015), and EMBASE(1991-2015). Searches were performed of article bibliographies and conference abstracts. MeS H and text words used included 'tumour regression', 'mr TRG', 'poor response' and 'colorectal cancers'. Clinical studies using either MRI or histopathological tumour regression grade(TRG) scales to define good and poor responders were included in relation to outcomes [local recurrence(LR), distant recurrence(DR), disease-free survival(DFS), and overall survival(OS)]. There was no age restriction or stage of cancer restriction for patient inclusion. Data were extracted by two authors working independently and using pre-defined outcome measures.RESULTS Quantitative data(prevalence) were extracted and analysed according to meta-analytical techniques using comprehensive meta-analysis. Qualitative data(LR, DR, DFS and OS) were presented as ranges. The overall proportion of poor responders after neo-adjuvant chemoradiotherapy(CRT) was 37.7%(95%CI: 30.1-45.8). There were 19 different reported histopathological scales and one MRI regression scale(mrT RG). Clinical studies used nine and six histopathological scales for poor and good responders, respectively. All studies using MRI to define good and poor response used one scale. The most common histopathological definition for good response was the Mandard grades 1 and 2 or Dworak grades 3 and 4; Mandard 3, 4 and 5 and Dworak 0, 1 and 2 were used for poor response. For histopathological grades, the 5-year outcomes for poor responders were LR 3.4%-4.3%, DR 14.3%-20.3%, DFS 61.7%-68.1% and OS 60.7-69.1. Good pathological response 5-year outcomes were LR 0%-1.8%, DR 0%-11.6%, DFS 78.4%-86.7%, and OS 77.4%-88.2%. A poor response on MRI(mr TRG 4,5) resulted in 5-year LR 4%-29%, DR 9%, DFS 31%-59% and OS 27%-68%. The 5-year outcomes with a good response on MRI(mrT RG 1,2 and 3) were LR 1%-14%, DR 3%, DFS 64%-83% and OS 72%-90%.CONCLUSION For histopathology regression assessment, Mandard 1, 2/Dworak 3, 4 should be used for good response and Mandard 3, 4, 5/Dworak 0, 1, 2 for poor response. MRI indicates good and poor response by mr TRG1-3 and mrT RG4-5, respectively.Muhammed RS Siddiqui Jemma Bhoday Nicholas J Battersby Manish Chand Nicholas P West Al-Mutaz Abulafi Paris P Tekkis Gina Brown 2016World Journal of Gastroenterology2016,22,37:6
2Application of positron emission tomography/computed tomography in radiation treatment planning for head and neck cancers显示文摘18-fluorodeoxygluocose positron emission tomography/computed tomography(18FDG-PET/CT) provides significant information in multiple settings in the management of head and neck cancers(HNC). This article seeks to define the additional benefit of PET/CT as related to radiation treatment planning for squamous cell carcinomas(SCCs) of the head and neck through a review of relevant literature. By helping further define both primary and nodal volumes, radiation treatment planning can be improved using PET/CT. Special attention is paid to the independent benefit of PET/CT in targeting mucosal primaries as well as in detecting nodal metastases. The utility of PET/CT is also explored for treatment planning in the setting of SCC of unknown primary as PET/CT may help define a mucosal target volume by guiding biopsies for examination under anesthesia thus changing the treatment paradigm and limiting the extent of therapy. Implications of the use of PET/CT for proper target delineation in patients with artifact from dental procedures are discussed and the impact of dental artifact on CT-based PET attenuation correction is assessed. Finally, comment is made upon the role of PET/CT in the high-risk post-operative setting, particularly in the context of radiation dose escalation. Real case examples are used in these settings to elucidate the practical benefits of PET/CT as related to radiation treatment planning in HNCs.Musaddiq J Awan Farzan Siddiqui David Schwartz Jiankui Yuan Mitchell Machtay Min Yao 2015World Journal of Radiology2015,7,11:2
3卒中介入治疗培训指南:国际多学会共识文件显示文摘1背景 缺血性卒中是全球人口死亡和残疾的首要原因。很多急性大血管闭塞(emergent large vesselocclusion,ELVO)患者都会遗留长期残疾。事实上,这些颅内大动脉闭塞经常会导致大面积脑损伤,进而造成患者死亡或严重致残。Lavine SD Cockroft K Hoh B Bambakidis N Khalessi AA Woo H Riina H Siddiqui A Hirsch JA Chong W Rice H Wenderoth J Mitchell P Coulthard A Signh TJ Phatorous C Khangure M Klurfan P ter Brugge K Iancu D Gunnarsson T Pongpech S Rodesch G Soderman M Taylor A Krings T Orbach D Picard L Suh DC Zheng HQ Jansen O Muto M Szikora I Pierot L Brouwer P Gralla J Renowden S Andersson T Fiehler J Turjman F White P Januel AC Spelle L Kulcsar Z Chapot R Biondi A Dima S Taschner C Szajner M Krajina A Sakai N Matsumaru Y Yoshknura S Ezura M Fujinaka T Iihara K Ishii A Higashi T Hirohata M Hyodo A Ito Y Kawanishi M Kiyosue H Kobayashi E Kobayashi S Kuwayama N Matsumoto Y Miyachi S Murayama Y Nagata I Nakahara I Nemoto S Niimi Y Oishi H Satomi J Satow T Sugiu K Tanaka M Terada T Yamagami H Diaz O Lylyk P Jayaraman MV Patsalides A Gandhi CD Lee SK Abruzzo T Albani B Ansari SA Arthur AS Baxter BW Bulsara KR Chen M Almandoz JE Fraser JF Heck DV Hetts SW Hussain MS Klucznik RP Leslie-Mawzi TM Mack WJ McTaggart RA Meyers PM Mocco J Prestigiacomo CA Pride GL Rasmussen PA Starke RM Sunenshine PJ Tarr RW Frei DF Pabo M Nogueira RG Zaidat OO Jovin T Linfante I Yavagal D Liebeskind D Novakovic R Pongpech S 许岩 孙瑞 郭芮兵 2017国际脑血管病杂志2017,25,5:2
4Extraction of high-viscosty gums from oats显示文摘WOOD P J SIDDIQUI L R PATON 19 1978Cereal Chem1978,55,6:1
5Ursodeoxycholic acid for the treatment of intrahepatic cholestasis of Pregnancy 显示文摘Laifer S A Stiller R J Siddiqui D S 2001J Matem Fetal Med2001,10,2:1
6NUT midline carcinomamimicking tonsillitis in an eight-year-old girl 显示文摘Rutt A L Poulik J Siddiqui A H ef al 2011Ann Otol RhinolLaryngol2011,120,8:1
7Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality显示文摘Osuehowski MF Weleh K Siddiqui J 2006J ImmunoI2006,177,:1
8Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality显示文摘Osuchowski MF Welch K Siddiqui J 2006J Immunol2006,177,3:1
9Epithelioid haemangioendothelioma of the thyroid gland : a case report and review of literature显示文摘Siddiqui M T Evans H L Ro J Y 1998Histopathology1998,32,5:1
10Hepatitis B virus X protein stimulates the mitochondrial translocation of Raf - 1 via oxidative stress 显示文摘Chen J Siddiqui A 2007J Virol2007,81,12:1
11Circulating cytokine/inhibitor profilfes reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality显示文摘Osuchowski MF Welch K Siddiqui J 2006J Immunol2006,177,3:1
12Inflammation, insulin resistance and carotid IMT in first degree relatives of north Indian type 2 diabetic subjects 显示文摘Ahmad J Ahmed F Siddiqui MA 2006Diabetes Res ccclin Pract2006,73,:1
13The role of serotonin (5-hydroxytryptaminelA and 1B) receptors in prostate cancer cell proliferation显示文摘Siddiqui E J Shabbir M Mikhailidis DP 2006J Urol2006,176,41:1
14Use of X - ray diffraction in assessing the aging pattern of asphalt fractions 显示文摘SIDDIQUI M N ALI M F SHIROKOFF J 2002Fuel2002,81,1:1
15Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality显示文摘Osuchowski M F Welch K Siddiqui J 0,,:1
16Urs0de0xyeh01ic acid for the treatment of intrahepatic cholestasis of pregnancy 显示文摘Laifer SA Stiller R J Siddiqui DS 2001J Matem Fetal Med2001,10,20:1
17Implementation of Rank based Sleep Scheduling(RBSS) Protocol for WSNs in a Fixed Grid Topology显示文摘Shehami T Siddiqui A J Abbasi H I 2013Procedia Computer Science2013,19,:1
18Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality显示文摘Osuchowski MF Welch K Siddiqui J 2006J Immunol2006,177,3:1
19Determination of β-glucan ill oats and barly 显示文摘Wood P J Paton D Siddiqui L R 1977Cereal Chem1977,54,3:1
20Membrane for the control of natural organic matter from surface waters显示文摘Siddiqui M Amyg Ruah J 2000Water Research2000,34,13:1
返回顶部 每页显示:
共23页 首页 上一页 第1页 下一页 末页 /23 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费